XTL Biopharmaceuticals Ltd Tangible Net Worth Ratio
XTL Biopharmaceuticals Ltd tangible net worth ratio. XTL Biopharmaceuticals Ltd (H2K2) has a Tangible Net Worth Ratio of 29.8% as of December 2024. This metric is calculated by deducting intangible assets (€3.82 Million) from net assets (€5.43 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check XTL Biopharmaceuticals Ltd (H2K2) strategic asset index to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of XTL Biopharmaceuticals Ltd (2016–2024)
Tangible net worth ratio of XTL Biopharmaceuticals Ltd from 2016 to 2024. This chart shows how XTL Biopharmaceuticals Ltd's Tangible Net Worth Ratio has changed across 9 annual periods from 2016 to 2024. As of December 2024, the ratio stands at 29.8%, reflecting net assets of €5.43 Million with intangible assets of €3.82 Million EUR. See XTL Biopharmaceuticals Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
XTL Biopharmaceuticals Ltd Tangible Net Worth Ratio by Year (2016–2024)
XTL Biopharmaceuticals Ltd tangible net worth ratio by year from 2016 to 2024. The table below presents the year-by-year Tangible Net Worth Ratio for XTL Biopharmaceuticals Ltd from 2016 to 2024, covering 9 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see H2K2 stock market capitalisation.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 29.8% | €5.43 Million | €3.82 Million | €8.55 Million | ▼ -53.1 pp |
| 2023 | 82.9% | €2.22 Million | €380.00K | €2.43 Million | ▼ -7.6 pp |
| 2022 | 90.5% | €4.00 Million | €380.00K | €4.19 Million | ▼ -2.4 pp |
| 2021 | 92.9% | €5.33 Million | €380.00K | €6.62 Million | ▼ -1.0 pp |
| 2020 | 93.9% | €6.25 Million | €380.00K | €6.50 Million | ▼ -0.6 pp |
| 2019 | 94.6% | €6.98 Million | €380.00K | €7.21 Million | ▼ -0.9 pp |
| 2018 | 95.4% | €8.32 Million | €380.00K | €8.57 Million | ▲ +5.9 pp |
| 2017 | 89.5% | €3.62 Million | €380.00K | €6.59 Million | ▼ -1.1 pp |
| 2016 | 90.6% | €2.69 Million | €253.00K | €3.02 Million | — |